Zobrazeno 1 - 10
of 1 790
pro vyhledávání: ''
Autor:
Michail Doukas, Merel van Pieterson, Sarah T A Teklenburg-Roord, Herbert M. van Wering, Lissy de Ridder, Dimitris Rizopoulos, Martinus A. Cozijnsen, Maria M E Jongsma, Obbe F. Norbruis, Michiel P. van Wijk, Marco W.J. Schreurs, Thalia Hummel, Johanna C. Escher, Janneke M. Stapelbroek, Michael Groeneweg, Kaija-Leena Kolho, Cathelijne van der Feen, Iva Hojsak, Tim G. J. de Meij, Janneke N. Samsom, M Aardoom, Victorien M. Wolters, Patrick F. van Rheenen
Publikováno v:
Jongsma, M M E, Aardoom, M A, Cozijnsen, M A, van Pieterson, M, de Meij, T, Groeneweg, M, Norbruis, O F, Wolters, V M, van Wering, H M, Hojsak, I, Kolho, K-L, Hummel, T, Stapelbroek, J, van der Feen, C, van Rheenen, P F, van Wijk, M P, Teklenburg-Roord, S T A, Schreurs, M W J, Rizopoulos, D, Doukas, M, Escher, J C, Samsom, J N & de Ridder, L 2022, ' First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: An open-label multicentre randomised controlled trial ', Gut, vol. 71, no. 1, pp. 34-42 . https://doi.org/10.1136/gutjnl-2020-322339
Gut, 71(1), 34-42. BMJ Publishing Group
Gut, 71, 34-42. BMJ PUBLISHING GROUP
Gut, 71(1), 34-42. BMJ Publishing Group
Gut, 71, 34-42. BMJ PUBLISHING GROUP
ObjectiveIn newly diagnosed paediatric patients with moderate-to-severe Crohn’s disease (CD), infliximab (IFX) is initiated once exclusive enteral nutrition (EEN), corticosteroid and immunomodulator therapies have failed. We aimed to investigate wh
Publikováno v:
International Journal of Oral and Maxillofacial Surgery. 50:1643-1648
Oral lichen planus (OLP) is a chronic non-infectious, inflammatory, immunological disease. In contrast to skin lesions, which are often self-limiting, oral lesions rarely heal on their own and can be resistant to local and systemic treatments. In thi
Publikováno v:
The Korean Journal of Internal Medicine
The Korean Journal of Internal Medicine, Vol 36, Iss 6, Pp 1281-1293 (2021)
The Korean Journal of Internal Medicine, Vol 36, Iss 6, Pp 1281-1293 (2021)
Previous research has investigated whether hyperuricemia serves as an independent risk factor for cardiovascular and renal diseases. Hyperuricemia is defined as an abnormally high level of uric acid (UA; i.e., serum urate level > 6.8 mg/dL). Hyperuri
Autor:
Toshihiko Kohashi, Shintaro Kuroda, Hirotaka Tashiro, Ichiro Ohmori, Tomoyuki Abe, Hideki Ohdan, Junko Tanaka, Akihiko Oshita, Koichi Oishi, Tsuyoshi Kobayashi, Takashi Onoe, Yasuhiro Imaoka
Publikováno v:
Surgery. 170:1140-1150
Background Posthepatectomy liver failure is a poor prognostic factor after hepatectomy. Various preventive treatments have been tried; however, there are no clinical trials that use posthepatectomy liver failure as the primary endpoint, and the clini
Autor:
William R. Drobyski, Nirav N. Shah, Walter L. Longo, Timothy S. Fenske, Bicky Thapa, Anita D'Souza, Sergey Tarima, Muhammad Bilal Abid, Saurabh Chhabra, Huaying Dong, Parameswaran Hari, Binod Dhakal, Mehdi Hamadani
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:e775-e781
Engraftment syndrome (ES) after autologous hematopoietic cell transplantation (AHCT) in multiple myeloma (MM) encompasses a continuum of periengraftment complications characterized by noninfectious fever, rash, diarrhea, and capillary leak features.W
Publikováno v:
Clinical Colorectal Cancer. 20:265-272
Liver-limited metastatic colorectal cancer is a potentially curable disease. Pathologic response (pR) to preoperative chemotherapy (CT) for colorectal liver metastases (CLM) is a surrogate endpoint for overall survival (OS). We conducted the first me
Autor:
Julien Taieb, Eloy Espin, Rea Lo Dico, Weitz Jürgen, Côme Lepage, Thibault Voron, Mehdi Karoui, Antoine Cazelles, Richard Douard, Alexis Buggenhout, Karine Le Malicot, F. Denimal, Matthieu Bruzzi, Fabio Cianchi
Publikováno v:
Digestive and Liver Disease. 53:1034-1040
Background In colon cancer (CC), surgery remains the mainstay of treatment with curative intent. Despite several clinical trials comparing open and laparoscopic approaches, data on long-term outcomes for stage III CC are lacking. Methods This post-ho
Autor:
Seyed Hossein Ardehali, Zahra Sahraei, Maryam Samsami, Omid Moradi, Saghar Barati, Mohammadreza Hajiesmaeili, Alireza Fatemi, Maria Tavakoli-Ardakani, Minoosh Shabani
Publikováno v:
Journal of Infection and Chemotherapy. 27:1181-1185
Introduction Nephrotoxicity remains a major long-standing concern for colistin, and it is critical to find agents that can prevent it. The present study aims to investigate the effect of vitamin E on the prevention of colistin-induced nephrotoxicity
Autor:
Wentao He, Jianhua Ma, Zhelong Liu, Xiaowen Chen, Jianhua Zhang, Shiyin Shao, Xuefeng Yu, Tao Zhao, Peiwen Liu, Liya Shen, Mei Lin, Yong Liao, Yanran Duan, Juping Hu, Jing Zhang, Shufang Hu, Yaoming Xue, Zhaoyang Zeng, Xi Chen, Yongping Xu, Liegang Liu, Shi Zhao, Wenjun Li, Jiaoe Zeng, Ping Yin
Publikováno v:
Endocrine Practice. 27:790-797
Many patients with type 2 diabetes treated with premixed insulin gradually have inadequate glycemic control and switch to a basal-bolus regimen, which raises some concerns for weight gain and increased hypoglycemic risk. Switching to combination use
Autor:
Désirée van der Heijde, Peter C. Taylor, Annelies Boonen, Robert Landewé, S. Cheng, Shannon McCue
Publikováno v:
Journal of rheumatology, 48(8), 1259-1267. Journal of Rheumatology
Journal of Rheumatology, 48(8), 1259-1267. Journal of Rheumatology Publishing Co. Ltd.
Journal of Rheumatology, 48(8), 1259-1267. J RHEUMATOL PUBL CO
Journal of Rheumatology, 48(8), 1259-1267. Journal of Rheumatology Publishing Co. Ltd.
Journal of Rheumatology, 48(8), 1259-1267. J RHEUMATOL PUBL CO
ObjectiveTo evaluate the efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with active ankylosing spondylitis (AS).MethodsThis phase III, multicenter, double-blind, placebo-controlled study (ClinicalTrials.gov: NCT